Edition:
India

Onconova Therapeutics Inc (ONTX.OQ)

ONTX.OQ on NASDAQ Stock Exchange Capital Market

1.69USD
17 Nov 2017
Change (% chg)

$0.02 (+1.20%)
Prev Close
$1.67
Open
$1.65
Day's High
$1.69
Day's Low
$1.63
Volume
8,881
Avg. Vol
24,820
52-wk High
$3.88
52-wk Low
$1.46

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 0.11 -0.707
Jun '17 0.32 -0.287
Mar '17 0.21 -1.232
FY 2016 Dec '16 0.17 -0.804
Sep '16 1.65 -0.294
Jun '16 2.25 -1.964
Mar '16 1.47 -2.650
FY 2015 Dec '15 9.60 1.279
Sep '15 1.62 -0.003
Jun '15 0.12 -4.125
Mar '15 0.11 -5.687
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-17 3 0.23 0.50 0.00 --
Year Ending Dec-17 3 0.86 1.10 0.64 0.00
Year Ending Dec-18 4 3.09 6.50 0.00 0.00
Earnings (per share)
Quarter Ending Dec-17 3 -0.72 -0.71 -0.72 -0.78
Year Ending Dec-17 3 -2.85 -2.79 -2.94 -3.30
Year Ending Dec-18 4 -2.08 -1.67 -2.64 -1.93
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 31.15 32.96
P/E High - Last 5 Yrs. -- 40.78 45.57
P/E Low - Last 5 Yrs. -- 23.79 24.35
Beta 0.14 0.90 0.89
Price to Sales (TTM) 7.31 3.94 5.25
Price to Book (MRQ) -- 4.83 5.40
Price to Tangible Book (MRQ) -- 5.47 6.73
Price to Cash Flow (TTM) -- 23.18 23.58
% Owned Institutions 26.87 0.77 1.29

Dividends

  Company industry sector
Dividend Yield -- 1.54 1.48
Dividend Yield - 5 Year Avg -- 1.54 1.49
Dividend 5 Year Growth Rate -- 4.38 5.23
Payout Ratio(TTM) -- 45.05 43.12

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -85.59 3.32 8.84
Sales (TTM) vs TTM 1 Yr. Ago -84.22 4.75 5.41
Sales - 5 Yr. Growth Rate 30.12 10.23 10.45
EPS (MRQ) vs Qtr. 1 Yr. Ago 85.38 16.20 19.37
EPS (TTM) vs TTM 1 Yr. Ago 21.60 -- --
EPS - 5 Yr. Growth Rate -- 10.04 10.96
Capital Spending - 5 Yr. Growth Rate -- 15.37 15.32

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.12 2.20
Current Ratio (MRQ) 1.62 2.91 3.00
LT Debt to Equity (MRQ) -- 8.63 10.82
Total Debt to Equity (MRQ) -- 12.47 14.95
Interest Coverage (TTM) -- 37.12 33.97

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 54.92 54.68
Gross Margin - 5 Yr. Avg. -- 52.01 52.15
EBITD Margin (TTM) -998.77 -- --
EBITD - 5 Yr. Avg -282.89 18.41 15.51
Operating Margin (TTM) -1,002.80 14.62 9.27
Operating Margin - 5 Yr. Avg. -285.00 14.52 11.18
Pre-Tax Margin (TTM) -761.54 15.10 10.08
Pre-Tax Margin - 5 Yr. Avg. -290.16 14.85 11.61
Net Profit Margin (TTM) -762.13 11.35 6.37
Net Profit Margin - 5 Yr. Avg. -290.86 11.16 7.88
Effective Tax Rate (TTM) -- 23.30 23.20
Effective Tax Rate - 5 Yr. Avg. -- 23.46 24.03

Efficiency

  Company industry sector
Revenue/Employee (TTM) 102,522 967,481,775 876,721,579
Net Income/Employee (TTM) -781,348 113,847,942 103,151,091
Receivable Turnover (TTM) 1.98 5.62 5.78
Inventory Turnover (TTM) -- 2.58 3.35
Asset Turnover (TTM) 0.15 0.96 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -111.27 11.53 11.10
Return on Assets - 5 Yr. Avg. -73.07 13.15 12.57
Return on Investment (TTM) -307.64 14.99 14.58
Return on Investment - 5 Yr. Avg. -96.91 17.20 16.46
Return on Equity (TTM) -4,335.58 16.33 16.09
Return on Equity - 5 Yr. Avg. -- 18.16 17.62
  1 Year 3 Year 5 Year
Sales % -51.59 5.28 30.12
EPS (TTM) % 57.87 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Onconova Therapeutics Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 25.17%
# of Holders: 17
Total Shares Held: 2,711,424
3 Mo. Net Change: 64,167
# New Positions: 2
# Closed Positions: 5
# Increased Positions: 7
# Reduced Positions: 7
# Net Buyers: 0
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.